trending Market Intelligence /marketintelligence/en/news-insights/trending/hhgr1jpd-bt-ejpsdafvug2 content esgSubNav
In This List

IBio gets NYSE noncompliance notice

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


IBio gets NYSE noncompliance notice

IBio Inc. said June 8 that it it fell out of compliance with NYSE American LLC listing requirements.

The New York biotechnology company received the notice because its stockholders' equity was below the exchange's $6 million minimum requirement, and it booked net losses in its five most recent fiscal years.

IBio has until July 6 to submit a plan showing how it intends to return to compliance by Dec. 6, 2019.